High Levels of Adhesion Molecules Are Associated with Impaired Endothelium-dependent Vasodilation in Patients with Peripheral Arterial Disease

Gregorio Brevetti; Vincenzo D. Martone; Tiziana de Cristofaro; Salvatore Corrado; Antonio Silvestro; Anna Maria Di Donato; Roxana Bucur; Francesco Scopacasa

doi:10.1055/s-0037-1612905

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2001; 85(01): 63-66
DOI: 10.1055/s-0037-1612905

Review Article

Schattauer GmbH

High Levels of Adhesion Molecules Are Associated with Impaired Endothelium-dependent Vasodilation in Patients with Peripheral Arterial Disease

Gregorio Brevetti

¹Departments of Medicine and Laboratory Medicine, University Federico II, Napoli, Italy

,

Vincenzo D. Martone

¹Departments of Medicine and Laboratory Medicine, University Federico II, Napoli, Italy

,

Tiziana de Cristofaro

²Departments of Laboratory Medicine, University Federico II, Napoli, Italy

,

Salvatore Corrado

¹Departments of Medicine and Laboratory Medicine, University Federico II, Napoli, Italy

,

Antonio Silvestro

¹Departments of Medicine and Laboratory Medicine, University Federico II, Napoli, Italy

,

Anna Maria Di Donato

¹Departments of Medicine and Laboratory Medicine, University Federico II, Napoli, Italy

,

Roxana Bucur

¹Departments of Medicine and Laboratory Medicine, University Federico II, Napoli, Italy

,

Francesco Scopacasa

²Departments of Laboratory Medicine, University Federico II, Napoli, Italy

› Author Affiliations

Abstract

Summary

Soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cellular adhesion molecule-1 (sVCAM-1) were measured alongside flow-mediated vasodilation (FMD) in 34 patients with intermittent claudication and 14 control subjects. Patients with plasma sICAM-1 >253 ng/mL (median value) showed lower FMD than those with sICAM-1 <253 ng/mL (5.6 ± 1.8% vs 9.6 ± 4.2%, p <0.01). Similarly, in the 17 patients with plasma sVCAM-1 >414 ng/mL, FMD was lower than in the remaining 17 patients (6.1 ± 1.9% vs 9.2 ± 4.5%, p <0.05). Additionally, when endothelial dysfunction was defined as FMD ≤5.5%, patients with FMD below this value had higher plasma concentrations of sICAM-1 and sVCAM-1 than those with FMD >5.5%. Therefore, our findings indicate a close association between elevated plasma levels of adhesion molecules and endothelial dysfunction. As impaired endothelial function is one of the first steps in atherogenesis, our findings have clinical relevance since they serve as the basis for further evaluation of sICAM-1 and sVCAM-1 as potential plasma markers for progression of atherosclerosis in a population at high risk.

Keywords

Adhesion molecules - flow-mediated dilation - endothelial dysfunction - intermittent claudication - peripheral arterial disease

Full Text

References

References
1 McDaniel MD, Cronewett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989; 3: 273-7.
2 Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 1994; 72: 128-32.
3 Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6.
4 Brevetti G, Martone VD, Perna S, Cacciatore F, Corrado S, Di Donato AM, Di Iorio A. Intermittent claudication and risk of cardiovascular events. Angiology 1998; 49: 843-8.
5 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
6 Entman ML, Ballantyne CM. Inflammation in acute coronary syndromes. Circulation 1993; 88: 800-3.
7 Albelda SM, Wayne Smith C, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-12.
8 Hwang S-J, Ballantyne CM, Sharrett R, Smith LC, Davis CE, Gotto AM, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The atherosclerosis risk in communities (ARIC) study. Circulation 1997; 96: 4219-25.
9 Ridker PM, Hennekens CH CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentrations of soluble intercellular adhesion molecule-1 and risk of future myocardial infarction in apparently healthy men. Lancet 1988; 351: 88-92.
10 Drexler H, Zeiher A, Wallsshlager H, Meinertz T, Just H, Bonzel T. Flow-dependent artery dilation in humans. Circulation 1989; 80: 466-74.
11 Anderson TJ, Ulhata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieherman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulation. J Am Coll Cardiol 1995; 26: 1235-41.
12 Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asyntomatic subjects related to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468-74.
13 Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340: 115-26.
14 Celermajer DS, Sorensen KE, Gooch VM, Spriegelhalter DJ, Miller OI, Sullivan ID, Lloyd JR, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
15 Cybulsky MI, Gimbrone MA. Endothelial expression of monocyte leukocyte adhesion molecule during atherogenesis. Science 1991; 251: 788-91.
16 Davies MJ, Gordon JL, Gearing AJH, Pigott R, Woolf H, Katz D, Kyriaopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM and E-selectin in human atherosclerosis. J Pathol 1993; 171: 223-9.
17 O’Brien KD, McDonald TO, Chait A, Allen MD, Alfers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996; 93: 672-82.
18 Adams DH, Mainolfi E, Elias E, Neuberger J M, Rothlein R. Detection of circulating intercellular adhesion molecule-1 after liver transplantation. Evidence of local release within the liver during graft rejection. Transplantation 1993; 55: 83-7.
19 Nakay K, Itoh C, Kawazoe K, Miura Y, Sotyanagi H, Hotta K, Itoh T, Kamata J, Hiramori K. Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coron Artery Dis 1996; 6: 497-502.
20 Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wierner-Kronish J, Matthay MA. Soluble E-selectin is found in supernatants of activaed endhotelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150: 644-54.
21 Lo SK, Lee S, Ramos RA, Lobb R, Rosa M, Chi-Rosso G W SD. Endothelial-leukocyte adhesion molecule-1 stimulates adhesive activity of leukocyte integrin CR3(Cd11b/CD, alpha m beta 2) on human neutrophils. J Exp Med. 1991; 173 (06) 1493-500.
22 Fezzi C, Desideri G, Baldoncini R, Bellini C, De Angelis C, Mazzocchi C, Santucci A. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 1998; 47: 660-7.
23 Davi G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bittolo Bon G. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998; 97: 953-7.
24 Belch JJ, MacKay IR, Hill A, Jerming P, McCollum P. Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Ang 1995; 14: 385-8.
25 Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 72: 151-4.
26 Peter K, Naworoth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsh A, Allenberg J, Kubler W, Bode C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997; 17: 505-12.